Beijing Okeanos Technology
Daxing
About Beijing Okeanos Technology
Okeanos offers a custom synthesis and production of special chemical biological reagents and pharmaceutical intermediates for life sciences. The company's main products are modified nucleotides, unnatural amino acids, heterocycle, and fluorescent and labeling reagents. Okeanos offers chemical compounds, pharmaceutical intermediates to the world-famous pharmaceutical companies, such as Pfizer, P&G Novartis, etc and enjoys a good reputation from the customers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $10K – $50K
- Total funding: $22.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2021)
- Website: okeanos.com.cn
- Phone: 86-10-62651721
Industries & Categories
Biopharma, Biotechnology, Chemical, Life Science, Pharmaceutical
Canonical: https://fsome.com/organization/beijing-okeanos-technology-48257 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.